Page last updated: 2024-10-18

alpha-glycerophosphoric acid and Tuberculosis, Multidrug-Resistant

alpha-glycerophosphoric acid has been researched along with Tuberculosis, Multidrug-Resistant in 1 studies

Tuberculosis, Multidrug-Resistant: Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chuang, YM1
Dutta, NK1
Hung, CF1
Wu, TC1
Rubin, H1
Karakousis, PC1

Other Studies

1 other study available for alpha-glycerophosphoric acid and Tuberculosis, Multidrug-Resistant

ArticleYear
Stringent Response Factors PPX1 and PPK2 Play an Important Role in Mycobacterium tuberculosis Metabolism, Biofilm Formation, and Sensitivity to Isoniazid In Vivo.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11

    Topics: Acid Anhydride Hydrolases; Animals; Antitubercular Agents; Biofilms; Citric Acid Cycle; Clofazimine;

2016